The potential of transcriptomic profiling to predict immune-checkpoint inhibitor (ICIs) response in locally advanced (La) and metastatic urothelial carcinoma (mUC).

被引：0
|
作者：
Caramelo, Belen
Munoz Unceta, Nerea
Freire, Javier
Varela, Ignacio
Martin, David
Del Carmen, Sofia
Azueta, Ainara
Diaz, Pilar
Garcia-Berbel, Pilar
Sagastibelza Marinelarena, Naiara
Rey-Cardenas, Macarena
Castellano, Daniel
Climent, Miguel Angel
Puente, Javier
Irure, Juan
Revuelta, Laura
Genre, Fernanda
Cacho, Diego
Gomez, Javier
Duran, Ignacio
机构：
[1] IDIVAL, Inst Invest Valdecilla, Santander, Cantabria, Spain
[2] Hosp Univ Marques de Valdecilla, Santander, Cantabria, Spain
[3] IBBTEC, Inst Biomed & Biotecnol Cantabria, Santander, Cantabria, Spain
[4] Hosp Donostia, San Sebastian, Spain
[5] Hosp Univ 12 Octubre, Madrid, Spain
[6] Hosp Univ 12 Octubre, Serv Oncol Med, Madrid, Spain
[7] Inst Valenciano Oncol, Valencia, Spain
[8] Hosp Clin Univ San Carlos, Med Oncol Dept, Madrid, Spain
[9] Hosp Univ Marques de Valdecilla, Dept Med Oncol, Santander, Cantabria, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 4_SUPPL期
关键词：
283-183-138-11076; 261-566-9718-9794; 298-4768-3691-2722-5055; 283-2494; 283-183-138-12268; 298-4768-12362; 261-492-5651-9270-5657; 6; 5; 3; 2; 38092-27449; 38092-25821; 1;
D O I：
10.1200/JCO.2024.42.4_suppl.668
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：668 / 668
页数：1
相关论文
共 50 条
  • [21] Immunological correlates of response and immune-mediated toxicity in checkpoint inhibitor (ICI)-treated metastatic urothelial carcinoma (mUC) patients (pts).
    Nizam, Amanda
    Tzeng, Alice
    Wei, Wei
    Rayman, Patricia A.
    Pavicic, Paul G.
    Makarov, Vladimir
    Juric, Ivan
    Alban, Tyler
    Swaidani, Shadi
    Sheng, Iris Yeong-Fung
    Gilligan, Timothy D.
    Gupta, Shilpa
    Diaz-Montero, C. Marcela
    Ornstein, Moshe Chaim
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [22] Current trends in the promising immune checkpoint inhibition and radiotherapy combination for locally advanced and metastatic urothelial carcinoma
    Takeshi Sano
    Ryoichi Saito
    Rihito Aizawa
    Tsubasa Watanabe
    Kaoru Murakami
    Yuki Kita
    Kimihiko Masui
    Takayuki Goto
    Takashi Mizowaki
    Takashi Kobayashi
    International Journal of Clinical Oncology, 2023, 28 : 1573 - 1584
  • [23] Current trends in the promising immune checkpoint inhibition and radiotherapy combination for locally advanced and metastatic urothelial carcinoma
    Sano, Takeshi
    Saito, Ryoichi
    Aizawa, Rihito
    Watanabe, Tsubasa
    Murakami, Kaoru
    Kita, Yuki
    Masui, Kimihiko
    Goto, Takayuki
    Mizowaki, Takashi
    Kobayashi, Takashi
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2023, 28 (12) : 1573 - 1584
  • [24] Biomarkers of the Response to Immune Checkpoint Inhibitors in Metastatic Urothelial Carcinoma
    Chen, Siteng
    Zhang, Ning
    Wang, Tao
    Zhang, Encheng
    Wang, Xiang
    Zheng, Junhua
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [25] Immune Checkpoint Inhibitor Therapy Before Nephrectomy for Locally Advanced and Metastatic Renal Cell Carcinoma
    Ghoreifi, Alireza
    Vaishampayan, Ulka
    Yin, Ming
    Psutka, Sarah P.
    Djaladat, Hooman
    JAMA ONCOLOGY, 2024, 10 (02) : 240 - 248
  • [26] Factors predictive of primary resistance (PrimRes) to immune checkpoint inhibitors (ICIs) in patients (pts) with metastatic urothelial cancer (mUC).
    Pramod, Nikhil
    Dawsey, Scott
    Patgunarajah, Ubenthira
    Lynn, David
    Wei, Wei
    Hobeika, Charbel
    Nair, Monica
    Martin, Allison
    Maroli, Kimberly
    Ornstein, Moshe Chaim
    Wee, Christopher Eing
    Gilligan, Timothy D.
    Nizam, Amanda
    Bonham, Amanda
    Mian, Omar Y.
    Pavicic, Paul G.
    Diaz-Montero, C. Marcela
    Gupta, Shilpa
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 703 - 703
  • [27] Immune-checkpoint inhibitors in previously treated patients with advanced or metastatic urothelial carcinoma: A systematic review and meta-analysis
    Di Nunno, Vincenzo
    De Luca, Emmanuele
    Buttigliero, Consuelo
    Tucci, Marcello
    Vignani, Francesca
    Gatto, Lidia
    Zichi, Clizia
    Ardizzoni, Andrea
    Di Maio, Massimo
    Massari, Francesco
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2018, 129 : 124 - 132
  • [28] Whole blood transcriptomic profiling to predict response to immunotherapy in metastatic urothelial cancer
    Van Wilpe, S.
    Ciarloni, L.
    Ehrensberger, S. Hosseinian
    Wosika, V.
    Schalken, J.
    Jeitziner, R.
    Angelino, P.
    Mehra, N.
    ANNALS OF ONCOLOGY, 2020, 31 : S596 - S596
  • [29] Characterizing immune-genomic signatures associated with response to immune checkpoint inhibitors (ICI) in patients with metastatic urothelial carcinoma (mUC)
    Pramod, Nikhil
    Dawsey, Scott
    Pavicic, Paul G.
    Lodha, Roshan
    Patgunarajah, Ubenthira
    Nair, Monica
    Ornstein, Moshe Chaim
    Gilligan, Timothy D.
    Wee, Christopher Eing
    Mian, Omar Y.
    Nizam, Amanda
    Nguyen, Jane
    Diaz-Montero, C. Marcela
    Gupta, Shilpa
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [30] Immune-Checkpoint Inhibitors for Advanced Hepatocellular Carcinoma: A Synopsis of Response Rates
    Shek, Dmitrii
    Read, Scott A.
    Nagrial, Adnan
    Carlino, Matteo S.
    Gao, Bo
    George, Jacob
    Ahlenstiel, Golo
    ONCOLOGIST, 2021, 26 (07): : E1216 - E1225
12345